People In The News

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – TrovaGene this week announced that it has named Antonius Schuh as CEO. Schuh previously served as chairman and CEO of Sorrento Therapeutics. He also has served as founding CEO of AviaraDx (now operating as BioTheranostics under parent company BioMérieux). Prior to that, he served as CEO of Arcturus, and president and CEO of Sequenom.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.